Nayan Nanavati, COO
Duration: 1 hour 15 minutes
OVERVIEW: Post-approval research is an evolving science. Over the last decade or so, post-approval studies have evolved – in their objectives, complexities and costs.
There have been significant changes in regulatory requirements as well. Yet, the approaches and tactics used to conduct post-approval studies has remained virtually the same.
With an evolving role and complexities of post-approval studies – and a shift toward patient centric outcomes – it is imperative that we revisit the way post-approval research is conducted.
- How do we maximize outcomes and ensure ROI in these large, often long-term studies?
- What are the unique and innovative ways to better engage patients and participating prescribing physicians to ensure successful outcomes?
More innovative and relevant operational processes, coupled with infusion of cutting-edge and smart technology, not only can address the needs of tech-savvy patients who demand ease-of-use and flexibility in reporting outcomes, but also can decrease the participating physician's administrative burden.
It's time to rethink cookie cutter approaches, and implement innovative, technology driven research to increase efficiencies, maximize outcomes, and address data collection from the patient perspective.
Join us for this insightful and thought-provoking session, and begin to rethink how post-approval research studies are done.
Who should attend:
Pharmaceutical, Biotech and Medical Device companies with a desire to conduct comprehensive and cost effective post-approval research for observational studies and large, simple trials.